Vascular endothelial cell growth factor-driven endothelial tube formation is mediated by vascular endothelial cell growth factor receptor-2, a kinase insert domain-containing receptor

被引:45
|
作者
Yang, SY
Xin, XH
Zlot, C
Ingle, G
Fuh, G
Li, B
Moffat, B
de Vos, AM
Gerritsen, ME
机构
[1] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Cardiovasc Res, San Francisco, CA 94080 USA
关键词
angiogenesis; lumen; kinase insert domain-containing receptor; vascular endothelial cell growth factor; endothelium;
D O I
10.1161/hq1201.099432
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vascular endothelial cell growth factor (VEGF) binds to 2 related receptor tyrosine kinases, known as kinase insert domain-containing receptor (KDR) and fins-like tyrosine kinase (Flt-1). The KDR has been shown to mediate VEGF-stimulated endothelial cell mitogenesis, migration. and permeability. The Flt-1 receptor has been suggested to mediate VEGF-stimulated endothelial branching morphogenesis, a process whereby endothelial cells, in the presence of a 3D milieu composed of extracellular matrix components and a mixture of growth factors, undergo a morphological transition into a tubular network with many lumina. In the present study, we have used 2 independent endothelial cell tube formation models and highly selective VEGF mutants for the KDR and Flt-1 receptors. We demonstrate that KDR, not Flt-1, stimulation is responsible for the induction of endothelial tubulogenesis. In addition, we demonstrate a modulatory role for Flt-1 in VEGF-mediated tube formation. We also report that VEGF-driven endothelial tube formation is inhibited by selective inhibitors of mitogen-activated protein kinase activation and p38 protein kinase.
引用
收藏
页码:1934 / 1940
页数:7
相关论文
共 50 条
  • [41] Ovarian vascular endothelial growth factor and vascular endothelial growth factor receptor patterns in reproductive aging
    Yeh, John
    Kim, Beom Su
    Peresie, Jennifer
    FERTILITY AND STERILITY, 2008, 89 : 1546 - 1556
  • [42] Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor
    Fuh, G
    Li, B
    Crowley, C
    Cunningham, B
    Wells, JA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (18) : 11197 - 11204
  • [43] Generation and characterization of a functional Nanobody against the vascular endothelial growth factor receptor-2; angiogenesis cell receptor
    Behdani, Mandi
    Zeinali, Sirous
    Khanahmad, Hossein
    Karimipour, Morteza
    Asadzadeh, Nader
    Azadmanesh, Keyhan
    Khabiri, Alireza
    Schoonooghe, Steve
    Anbouhi, Mahdi Habibi
    Hassanzadeh-Ghassabeh, Gholamreza
    Muyldermans, Serge
    MOLECULAR IMMUNOLOGY, 2012, 50 (1-2) : 35 - 41
  • [44] A receptor for vascular endothelial growth factor that stimulates endothelial apoptosis
    Quinn, TP
    Soifer, SJ
    Ramer, K
    Williams, LT
    Nakamura, MC
    CANCER RESEARCH, 2001, 61 (24) : 8629 - 8637
  • [45] Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck
    Neuchrist, C
    Erovic, BM
    Handisurya, A
    Fischer, MB
    Steiner, GE
    Hollemann, D
    Gedlicka, C
    Saaristo, A
    Burian, M
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2003, 25 (06): : 464 - 474
  • [46] Rapamycin Inhibits Lymphatic Endothelial Cell Tube Formation by Downregulating Vascular Endothelial Growth Factor Receptor 3 Protein Expression
    Luo, Yan
    Liu, Lei
    Rogers, Donna
    Su, Wei
    Odaka, Yoshinobu
    Zhou, Hongyu
    Chen, Wenxing
    Shen, Tao
    Alexander, J. Steven
    Huang, Shile
    NEOPLASIA, 2012, 14 (03): : 228 - 237
  • [47] Crystallization of the receptor binding domain of vascular endothelial growth factor
    Christinger, HW
    Muller, YA
    Berleau, LT
    Keyt, BA
    Cunningham, BC
    Ferrara, N
    deVos, AM
    PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1996, 26 (03): : 353 - 357
  • [48] Vascular Endothelial Growth Factor and Type 2 Receptor for This Factor in Vascular Malformations
    Pavlov, K. A.
    Gershtein, E. S.
    Dubova, E. A.
    Shchegolev, A. I.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2011, 150 (04) : 481 - 484
  • [49] Inhibitors of the vascular endothelial growth factor receptor
    Rosen, LS
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2002, 16 (05) : 1173 - +
  • [50] Vascular Endothelial Growth Factor and Type 2 Receptor for This Factor in Vascular Malformations
    K. A. Pavlov
    E. S. Gershtein
    E. A. Dubova
    A. I. Shchegolev
    Bulletin of Experimental Biology and Medicine, 2011, 150 : 481 - 484